The brainstem provides most of the noradrenaline (NA) present in the spinal cord, which functions to both 22 increase spinal motoneuron excitability and inhibit sensory afferent transmission to motoneurons 23 (excitatory postsynaptic potentials; EPSPs). NA increases motoneuron excitability by facilitating calcium-24 mediated persistent inward currents (Ca PICs) that are crucial for sustained motoneuron firing. Spinal cord 25 transection eliminates most NA and accordingly causes an immediate loss of PICs and emergence of 26 exaggerated EPSPs. However, with time PICs recover, and thus the exaggerated EPSPs can then readily 27 trigger these PICs, which in turn produce muscle spasms. Here we examined the contribution of adrenergic 28 receptors to spasms in chronic spinal rats. Selective activation of the α 1A adrenergic receptor with the 29 agonists methoxamine or A61603 facilitated Ca PIC and spasm activity, recorded both in vivo and in vitro. 30
INTRODUCTION 43
In the months following a spinal cord injury (SCI) individuals often develop a debilitating spastic 44 syndrome, consisting of increased muscle tone, clonus, exaggerated reflexes and associated widespread 45 muscle spasms (Ashby 1987 The goal of this paper was to understand the role of adrenergic receptors in these two processes. 55 56 Normally, the control of both motoneuron excitability and sensory transmission depends on descending 57 monoaminergic drive, including noradrenaline (NA) and serotonin (5-HT), originating primarily from the 58 brainstem and providing the spinal cord with a state-dependent control of excitability (Fung et al. 1991 2006c; Lee and Heckman 1999) . These monoamine-dependent PICs are essential for motoneuron function, 65 amplifying synaptic inputs to motoneurons and providing the basic capacity for sustained depolarization 66 and firing (Harvey et al. 2006b ; Hounsgaard et al. 1988 ; Lee and Heckman 2000) . Importantly, adrenergic 67 spontaneous activity was undetermined. Subsequently, Murray et al (2010b) demonstrated that 93 spontaneous activity of the 5-HT 2 receptors occurs in the absence of any residual 5-HT, due to constitutive 94 receptor activity (defined as receptor activity in the absence of any neurotransmitter). Similar constitutive 95 activity may account for spontaneous adrenergic receptor activity in SCI, since adrenergic receptors are 96 known to exhibit constitutive activity in reduced single cells systems (Rossier et al. 1999 ; Seifert and 97 Wenzel- Seifert 2002) . Additionally, it is likely that residual NA in the spinal cord may also contribute to 98 adrenergic receptor activity, because increasing endogenous NA release via amphetamine increases 99 reflexes, spasms and Ca PICs after complete spinal cord transection (Nozaki et al. 1980 ; Rank et al. 2007) . 100
We tested these ideas in the present paper, employing both a novel antagonist that blocks only 101 conventional NA-activated receptor activity (neutral antagonist, REC15/2739) (Rossier et al. 1999) and 102
antagonists that block constitutive receptor activity (inverse agonists, WB4101 and prazosin) (Rossier et al. 103 1999; Seifert and Wenzel-Seifert 2002) . 104
105
While Harvey et al. (2006b) suggest that α 1 adrenergic receptors contribute to spasms after SCI, the 106 specific receptor subtype is unknown (α 1A , α 1B , α 1D). Furthermore, even in the normal motoneurons it 107 remains uncertain which adrenergic receptors modulate motoneuron PICs, because previous studies of 108 adrenergic modulation of PICs (Lee and Heckman 1999 ) employed non-selective agonists (e.g. 109 methoxamine) that likely activated both α 1 and α 2 adrenergic receptors (U' Prichard et al. 1977 ). Thus, prior 110 to examining the origin of the spontaneous adrenergic receptor activity, we first identified the specific 111 receptors that modulate PICs, EPSPs and spasms using selective activation of receptor subtypes with 112 agonists. 113
114
In addition to the facilitatory actions of descending NA on spinal motoneurons, NA also inhibits sensory 115 afferent transmission to motoneurons and ascending sensory systems (Jankowska et al. 1993; Lundberg 116 1982; Millan 2002; Yoshimura and Furue 2006) . For example, NA inhibits afferent transmission from low 117 threshold group I and II muscle and cutaneous afferents, thereby inhibiting polysynaptic flexor reflexes 118 (Clarke et al. 2002; Li et al. 2004b; Lundberg 1982 ). Thus, with SCI there is an immediate loss of this 119 inhibition (disinhibition), leading to the emergence of unusually long polysynaptic EPSPs evoked by 120 stimulation of group I and II afferents in both rats (Baker and Chandler 1987; Li et al. 2004a ) and humans 121 (Norton et al. 2008 ). Since Ca PICs require depolarizations of about half a second to be fully activated (Li 122 and . Thus, another goal of this paper was to determine whether 132 the α 2 receptor inhibits the long EPSP that mediates spasms, and whether loss of ligand-activated receptor 133 activity after SCI is partly compensated for by spontaneous activity in α 2 adrenergic receptors. 134
135

METHODS 136
Adult female Sprague-Dawley rats with chronic SCI resulting in fully developed spasticity, and normal, 137 previously unlesioned adult rats were utilized in this study. Rats received a complete sacral spinal (S 2 ) 138 transection at 45 -55 days old, as previously detailed (Bennett et al. 1999; Bennett et al. 2004 ). All 139 experiments on chronic spinal rats were conducted after full spasticity had developed in the axial muscles 140 of the tail (2 -3 months after transection). Experiments on normal rats were conducted at a similar age (3 -141 6 months old). Recordings were made from sacrocaudal motoneurons and ventral roots of normal and 142 chronic spinal rats in vitro (Li et al. 2004a; Li et al. 2004b ). Muscle spasms were also recorded in vivo via 143 percutaneous EMG placed in the axial tail muscles of spastic chronic spinal rats (Murray et al. 2010b ). All 144 procedures were approved by the University of Alberta Animal Care and Use Committee: Health Sciences. 145
146
In vitro preparation 147
Details of the in vitro preparation have been previously described in detail (Li et al. 2004a; Li et al. 148 2004b), and are only briefly summarized here. Rats were deeply anaesthetized with urethane (0.18 g/100 149 g; with a maximum dose of 0.45 g) and the whole sacrocaudal spinal cord was removed and transferred to 150 a dissection chamber filled with modified artificial cerebrospinal fluid (mACSF) maintained at a constant 151 temperature of 20° C. To remove the cord in chronic spinal rats a transection was made just above the 152 chronic injury (at upper S 2 level). In normal adult rats the cord was cut at the same location (upper S 2 ) for 153 removal, and they are therefore termed acute spinal rats. All dorsal and ventral spinal roots were removed, 154 with the exception of the sacral S 4 and caudal Ca 1 ventral roots and the Ca 1 dorsal roots. The cord was then 155 allowed to rest in the dissection chamber for 1.5 hrs. Following this rest period, the cord was transferred to 156 a recording chamber containing continuously flowing normal artificial cerebrospinal fluid (nACSF) 157 maintained near 24° C and with a flow rate > 5 mL/min. Following a 60 min nACSF wash out period to 158 clear any residual anaesthetic and mACSF, the nACSF was recycled in a closed system with a peristaltic 159 pump. 160
161
Intracellular recordings and analysis 162
Intracellular recordings were made from motoneurons in the sacrocaudal spinal cord of chronic spinal rats, 163 as detailed elsewhere (Li et al. 2004a) , and are only briefly summarized here. Sharp intracellular 164 electrodes were made from thick-walled glass capillary tubes (1.5 mm O.D.; Warner GC 150F-10) using a 165
Sutter P-87 micropipette puller. Electrodes were back-filled with a combination of 1M potassium acetate 166 and 1 M KCl. A stepper-motor micromanipulator (660 Kopf) was used to advance into motoneurons. 167
After penetration, motoneuron identification was made with antidromic stimulation of the S 4 and Ca 1 168 ventral roots noting ventral horn location, input resistance and time constant (> 6 ms for motoneurons) (Li 169 et al. 2007 ). Data were collected with an Axoclamp 2b intracellular amplifier (Axon Instruments, 170
Burlingame, CA) running in discontinuous current clamp (DCC, switching rate 4 -6 kHz, output 171 bandwidth 3.0 kHz, sample rate of 6.7 kHz) or discontinuous single-electrode voltage clamp (SEVC; gain 172 0.8 to 2.5 nA/mV) modes. To measure the basic electrical properties of motoneurons slow triangular 173 current ramps (0.4 nA/s) and voltage ramps (ramp speed 3.5 mV/s) were applied. Resting potential (V m ) 174 was recorded 15 mins after cell penetration, allowing time for the cell to stabilize, with a bias current of 0 175 nA. The input resistance (R m ) was measured during the voltage ramps over a 5 mV range near resting 176 membrane potential and subthreshold to PIC onset. PIC measurements were made during the slow 177 triangular voltage ramps. Firstly, the passive leak current was estimated during the upward portion of the 178 ramp where the current response initially increases linearly with voltage in response to the passive leak 179 conductance. A linear relation was fit to the subthreshold current response 5 -10 mV below the negative-180 slope region of the PIC onset, and then extrapolated to more positive voltages. The PIC amplitude was 181 then estimated by subtracting this leak current from the total recorded current (leak-subtracted current). 182
The onset voltage for the PIC (V on ) was measured at the beginning of the first negative slope region in the 183 current (where first zero slope in current response occurred). The peak current of the PIC was measured 184 from the leak subtracted current, where the downward deviation below the leak line reached peak 185 amplitude. EPSPs and associated reflexes were also measured in motoneurons after stimulating the Ca 1 186 dorsal roots (at 3 x threshold, T) while applying a hyperpolarizing bias current to block the PICs, and peak 187 value quantified at about 200 ms after the stimulation (long polysynaptic EPSP). Data were analysed in 188 
Drugs and Solutions 215
Two kinds of artificial cerebrospinal fluid were used in these experiments; a modified ACSF (mACSF) 216 used during dissection and recovery to minimize neural and metabolic activity and a normal ACSF 217 (nACSF) in the recording chamber. The mACSF was composed of (in mM) 118 NaCl, 24 NaHCO3, 1.5 218 CaCl2, 3 KCl, 5 MgCl2, 1.4 NaH2PO4, 1.3 MgSO4, 25 D-glucose, and 1 kynurenic acid. Normal ACSF 219 was composed of (in mM) 122 NaCl, 24 NaHCO3, 2. All data are shown as mean ± standard error throughout the text and figures. Statistical differences were 265 computed at a significance level of P < 0.05 with a paired Student's t-test where data were before and after 266 drug applications in the same animals, and otherwise with an unpaired Student's t-test or ANOVA as 267 needed. A Kolmogorov-Smirnov test for normality was applied to each data set, with the level set for 268 significance set to P = 0.05, to verify normality, as is required for a t-test. Where dose-response curves are 269 presented a standard sigmoidal curve (with a Hill slope of unity) was fit to LLR responses with increasing 270 drug doses (in log units). Drug potency, as indicated by the dose at which 50% of the maximal effect was 271 observed (EC50), was measured from the curve. All calculations of EC50 values and accompanying 272 statistics comparing EC50 values were carried out using the logarithm of dose. 273
274
RESULTS 275
Ca PICs are increased by α 1 receptors 276
Considering that Ca PICs in motoneurons are a major underlying cause of spasms after SCI, we began our 277 study by examining the effect of α 1 receptor activation on Ca PICs. The Ca PICs were quantified in vitro 278 during intracellular recordings from motoneurons in the sacral spinal cord of chronic spinal rats (Fig 1) . 279 TTX (2 μM) was applied to synaptically isolate the motoneuron (blocking spike-mediated transmission) 280 and to block the Na PIC that otherwise can obscure the Ca PIC, as previously described (Li window (500 -4000 ms, LLR and spasm used interchangeably; Fig 1C) . The adrenergic agonists A61603, 331 methoxamine and phenylephrine were applied locally to the spinal cord by intrathecal injection (IT, 0.1 -1 332 mM in 30 μl saline), to avoid systemic effects. Again, we found that, by themselves, none of these agonists 333 increased LLRs (spasms) in all rats tested (n = 7/7 rats tested; data not shown), though in two of these 334 animals A61603 induced a regular rhythmic movement of the tail in the absence of spasm-triggering 335 stimulation. In contrast, after a prior application of RX821002 (1 -3 mg/Kg, IP) to block possible non-336 selective actions on α 2 receptors, LLRs (tail spasms) were significantly increased by an IT injection of 337 A61603 (Fig 1C, F) . Control saline injections had no significant effect (P > 0.05, n = 5; not shown). These 338 results further demonstrate that activation of the α 1A adrenergic receptor increases spasticity and 339 underlying Ca PICs in chronic spinal rats. 340
341
Chronic spinal rats are not supersensitive to α 1 receptor activation. 342
The increases in LLRs resulting from α 1 adrenergic receptor activation were not limited to chronic spinal 343 animals. Application of A61603 also lead to increases in LLRs recorded in normal control rats studied in 344 vitro (considered acute spinal because of cord removal for in vitro recording; Fig 1G; in RX821002). For 345 these acutely spinalized rats, LLRs were initially absent (ie. animals were not spastic). To ensure similar 346 preliminary conditions, a low dose of strychnine was administered in vitro which resulted in LLRs that 347
were similar in magnitude to those in chronic spinal rats (only slightly smaller; Fig 1E vs Fig 1G) . The 348 increase in LLRs produced by A61603 in these acutely spinalized control rats, with strychnine, was 349 comparable to that seen in chronic spinal animals (Fig 1E vs Fig 1G) . Moreover, the dose at which 350 A61603 exerted half of its maximal effect on in vitro LLRs (EC50) was similar in both chronic and acutely 351 lesioned rats, indicating a lack of supersensitivity to α Shibata et al. 1995) , and for that reason we used these drugs to 358 confirm the involvement of the α 1 receptors in facilitating LLRs in chronic spinal rats. We found that the 359 facilitation of the LLR by A61603 (in presence of RX821002, as above) was significantly inhibited by a 360 subsequent application prazosin or REC15/2739 (Fig 2A, B, D, E) , in vitro. The typical time course of the 361 facilitation of the LLR by the α 1 agonist and subsequent inhibition by and the α 1 antagonist is shown in Fig  362   2B , with the antagonist acting relatively slowly, taking > 30 mins to reach peak effect. Part of this 363 antagonist-mediated inhibition might have resulted from a block of endogenously active α 1 receptors (see 364 below). Thus, we also evaluated the action of increasing doses of the agonist A61603 on the LLR after first 365 applying the antagonist and giving time for the intrinsic effects of this antagonist, if any, to reach steady 366 state (agonist given > 30 mins after antagonist). In this situation, increasing doses of the agonist A61603 367 had no effect until very high doses were reached (1000 nM), whereas without the antagonist A61603 368 increased the LLR at doses as low as 10 nM, demonstrating that this agonist indeed increased the LLR and 369 associated PICs via α 1 receptors. These experiments were performed in the presence of RX821002 to rule 370 out any non-selective action of A61603 on the α 2 receptor. 371
The drug REC15/2739 is special because it has previously been shown to act as a neutral antagonist at α 1A 376 adrenergic receptors, meaning that it blocks only the action of a ligand (such as NA) at the α 1A receptor, 377
and not constitutive receptor activity (Rossier et al. 1999 ). REC15/2739 is therefore useful in determining 378 whether the α 1A receptors are activated by endogenous NA, or another natural ligand, that somehow 379 persists below a chronic spinal injury. We found that administration of REC15/2739 alone had no effect on 380 the ventral root LLRs in the isolated in vitro spinal cord (Fig 3A, C) , even though it readily antagonized 381 the α 1A agonist A61603 (Fig 2E) . This suggests that, at least in vitro, the α 1A receptor is not endogenously 382 activated by residual NA in the spinal cord. In contrast, when we administered REC15/2739 in awake 383 spastic rats in vivo, with a localized IT injection, there was a significant decrease in LLRs (spasms Fig 3B, inhibited the LLRs (spasms Fig 3D) , which is likely due to both a block of ligand-activated receptors 398 (residual NA) and constitutively activated receptors. 399
400
The α 2 adrenergic receptor modulates the EPSP, but not the Ca PIC 401
Considering that we suspected an inhibitory effect of α 2 receptors on the EPSPs that trigger LLRs 402 (spasms), we next measured how the moderately selective α 2 adrenergic (and imidazoline I 1 ) receptor 403 agonist clonidine, and the highly selective α 2A adrenergic receptor agonist UK14304, affected ventral root 404
LLRs in vitro. Treatment with both these α 2 agonists significantly decreased LLRs (Fig 4A, D) , and this 405 decrease was reversed by subsequent treatment with the selective α 2 adrenergic antagonist RX821002 (Fig  406   4A, D) . Furthermore the decease in the LLR with clonidine was dose dependent, with a very low EC50 of 407 25 ± 7 nM, consistent with the high binding affinity of clonidine to the α 2A receptor (K i = 31 nM) (Millan 408 et al. 2000) , and inconsistent with the 10 times lower affinity of clonidine to α 1 receptors (e.g. K i = 300 nM 409 at α 1A receptor) (Millan et al. 2000) . These results suggest that α 2A adrenergic receptors inhibit LLRs and 410 resulting spasms after chronic SCI. 411
412
We next investigated whether this inhibitory effect of α 2 receptors was mediated by a reduction in the 413 dorsal root evoked long polysynaptic EPSP that triggers the PICs, or the PICs themselves that ultimately 414 cause the many seconds of firing during the LLRs (spasms). We recorded EPSPs in motoneurons of 415 chronic spinal rats in response to our standard brief dorsal root stimulation (0.1 ms, 3 x T; Fig 4C) . The 416 motoneurons were held with a hyperpolarizing bias current in order to prevent PIC activation and spiking 417
(holding cell at -80 mV), and thus allow us to investigate the EPSP in isolation (Li et al. 2004a ). Under 418 these conditions, a long EPSP was evoked with a 5 -10 ms latency, lasting about 500 -1000 ms, and 419 with a mean amplitude of 5.2 ± 2.1 mV measured at 250 ms post-stimulation (at main peak after transient 420 peak at 5 -10 ms). The α 2 receptor agonist clonidine decreased this long polysynaptic EPSP significantly 421 (Fig 4C, E) . In contrast, clonidine had no effect on the PIC (Fig 4F; recorded under voltage clamp, as 422 described in Fig 1A) . Interestingly, clonidine significantly hyperpolarized the resting membrane potential 423 by about -4 mV (Fig 4) . These data suggest that the inhibitory effect of the α 2 receptor on spasms is 424 mediated by a reduction of the long polysynaptic EPSP that trigger the PICs (and associated spasms), 425 rather than by a reduction in the PICs themselves. Additionally, this receptor may act by hyperpolarizing 426 the motoneurons. 427
428
Lack of constitutive activity in α 2 receptors. 429
Application of the α 2 adrenergic receptor antagonist RX821002 alone, without agonists, had no effect on 430 the LLRs (Fig 4B and Fig 5A, C) measured in the isolated spinal cord in vitro, even though it is a potent α 2 431 receptor inverse agonist that is capable of blocking constitutively active α 2 receptors (Pauwels et al. 2000) . 432
In contrast, RX821002 significantly increased the spasms recorded in the awake spastic rat in vivo, both 433 with systemic intraperitoneal (IP) or local spinal intrathecal injection of RX821002 (Fig 5D, E) . This 434 suggests that, although the α 2 adrenergic receptor is not constitutively in the isolated in vitro spinal cord, it 435 is activated by some endogenous ligand (NA) present below the lesion in the awake rat after chronic SCI, 436 similar to the activation of the α 1 receptor. 437
The results of our study characterize for the first time the roles of two adrenergic receptor subtypes (α 1 and 440 α 2 ) in the recovery of motoneuron excitability and spasms after chronic SCI. We find that α 1 receptors 441 increase motoneuron excitability and the α 2 receptors decrease synaptic transmission of sensory inputs to 442 motoneurons, and thus have opposing effects on motor output and spasms after injury, broadly consistent 443 with our understanding of the function of these receptors in normal uninjured animals (Jankowska and 444 . Notably, we demonstrate a previously undescribed mechanism for compensating for loss of 446 adrenergic innervation with SCI: α 1 receptors become constitutively active (active in absence of NA) and 447 this ultimately contributes to both the recovery of motoneuron excitability (PICs) and emergence of 448 spasms (uncontrolled PICs). Interestingly, we find that a peripheral source of NA, or potentially another 449 ligand, additionally activates the α 1 and α 2 receptors. In contrast, the α 2 receptors do not seem to exhibit 450 constitutive activity, suggesting that these receptors respond differently to injury. Our results specifically establish that activation of the α 1A adrenergic receptor facilitates the Ca PIC in 454 motoneurons, thereby increasing its excitability, and ultimately increasing the many second long spasms 455 (LLRs), known to be mediated by the Ca PIC. These conclusions are based on α 1A receptor agonist-456 induced increases in the Ca PICs, measured both directly with intracellular recordings and indirectly by 457 assessing the many seconds long ventral root LLRs produced by the Ca PICs, the latter allowing more 458 detailed pharmacological testing not possible during intracellular recordings. We specifically used the 459 highly selective α 1A agonist A61603 that has negligible binding affinity for most other receptors, including 460 other α 1 adrenergic receptor subtypes (α 1B , α 1D ), β adrenergic receptors, dopamine receptors and 5-HT 461 receptors (Craig et al. 1997; Mehrotra et al. 2007 ). The only non-selective action of A61603 is to bind with 462 high affinity to α 2 receptors (Craig et al. 1997 ), which initially thwarted our efforts to demonstrate α 1A 463 receptor-mediated increases in the LLR, and thus we subsequently applied A61603 in the presence of the 464 α 2 antagonist RX821002 to make it highly selective to α 1 receptors. Under these conditions we found that 465 A61603 consistently increases the LLR, demonstrating the presence of an α 1A adrenergic receptor that 466 facilitates the Ca PIC on motoneurons. receptor has been shown to depolarize other motoneurons (Rekling et al. 2000) , bringing them closer to 487 threshold and making them more likely to be involved in spastic reflexes (spasms). While we found that 488 the α 1 agonist methoxamine did not depolarize the resting potential of motoneurons, it is still possible that 489 the α 1 receptor depolarizes the sacral motoneurons we studied, but this is masked by the non-selective 490 action of methoxamine on the α 2 receptor, which hyperpolarizes motoneurons (see below). We do not 491 know whether the α 1 receptors facilitate sensory afferent transmission (EPSPs), though if anything they 492 may do the opposite, by facilitation of inhibitory interneurons (Yoshimura and Furue 2006) . 493 494 α 1A receptors act similarly in normal and chronic spinal rats. 495
In spinal cords from normal rats, we also found evidence for the presence of α 1A receptor activation on 496 motoneurons that likely act to increase the Ca PICs, because A61603 application (with RX821002) 497 increases sustained motoneuron output in spinal cords of normal rats. Interestingly, when we bring 498 motoneurons of normal and chronic spinal rats to a similar initial level of excitability prior to testing with 499 A61603, by applying a low dose of strychnine in normal rats, the estimated potency of this receptor agonist 500 (EC50) is similar in normal and chronic spinal rats, suggesting that the α 1A receptor-mediated responses 501 may not become supersensitive with injury. This is contrary to previous suggestions (Li et al. 2004b ) and 502 unlike the supersensitivity of motoneuron PICs to 5-HT receptor activation after chronic injury (Harvey et 503 al. 2006a ). However, a lack of supersensitivity in chronic spinal rats (60 -90 days post injury) is consistent 504 with previous findings that, while the α 1 receptor expression is up regulated transiently after SCI (Giroux 505 et al. 1999; Roudet et al. 1993) , it reverts back to normal expression at > 30 days post injury. Caution must 506 be taken in comparing receptor expression to agonist potency in facilitating reflexes though, because 507 increasing receptor number does not necessarily increase the potency of agonists. Furthermore in normal 508 animals agonists are more likely to be sequestered by the potent NA reuptake transporter (NET) than after 509 SCI, where NET must be reduced with loss of NA innervation, considering its predominant localization on 510 catecholamine neurons and not glial cells (Blakely et al. 1994) . Currently, it is only clear that the REC15/2739), we can now re-interpret our previous finding that WB4101 also decreases sodium currents 525 in motoneurons in chronic spinal rats (Harvey et al. 2006b ). This now indicates that constitutive α 1 526 adrenergic receptor activity also facilitates sodium currents, including Na PIC and the fast sodium currents 527 underlying the spike. we only know that one of the α 1 receptor types is constitutively active. However, while REC15/2739 is a 534 neutral antagonist at α 1A receptors, it is an inverse agonist at other α 1 receptor subtypes, whereas WB4101 535 and prazosin are inverse agonist at all α 1 receptor subtypes (Rossier et al. 1999 ). Thus the inhibition of the 536 LLR by WB4101 and prazosin, and not REC15/2739, indicates that the constitutive activity is mediated by 537 the α 1A receptor, further supporting the conclusion that the α 1A receptor increases the Ca PIC. spinal cord, and so there is a central store of NA, but this store does not appear to be actively released, at 559 least under our experimental conditions in vitro. In contrast, the endogenous α 1 receptor activity seen in the 560 awake rats (in vivo) appears to additionally involve α 1 receptors activated by an endogenous ligand 561 (presumably NA), because both the inverse agonists and the neutral antagonist reduce spasms in this case. 562
We do not known where this source of NA arises, but do know that it acts at the spinal level because we 563 increases in the PICs and spasms that we observe in vitro (Rank et al. 2007 ), but we reiterate that this 573 intrinsic source appears to be functionally inactive in the isolated spinal cord (in vitro; lack of effect of 574 REC15/2739). Considering the very sparse distribution of these few residual NA fibres after SCI, and the 575 lack of supersensitivity to α 1 receptors to NA agonists, this sympathetic source of NA seems unlikely to 576 account for the large PICs and spasms we see. Alternatively, since the blood brain barrier (BBB) is 577 chronically compromised after SCI (Popovich et al. 1996) , peripheral circulating NA originating in the 578 autonomic system, may crosses into the spinal cord and activate the α 1 receptors. While unconventional, 579 this peripherally-derived NA seems like a much larger source of NA, and we are currently investigating 580 this possibility. 581 582 α 2 receptors inhibit EPSPs, but not PICs. 583
Contrary to the α 1 receptor function, our data demonstrate that the activation of the α 2 adrenergic receptor 584 has no direct effect on the Ca PIC in motoneurons (clonidine-resistant). Rather, activation of the α 2 585 receptor with clonidine inhibits sensory synaptic transmission to the motoneuron, decreasing the 586 polysynaptic EPSP and thereby preventing activation of the Ca PIC and ultimately reducing the activation 587 of LLRs. We do not know where these α 2 receptors are located, though they are likely on the terminals of 588 the low threshold group I and II sensory afferents that we used to evoke LLRs and EPSPs, or on the 589 interneurons involved in the polysynaptic pathway that produces the EPSPs, consistent with previously 590 reported locations of α 2 receptors ( Unlike the α 1 receptor, the α 2 receptor does not appear to be constitutively active after SCI, because 604 blocking possible constitutive activity with the α 2 antagonist RX821002, an inverse agonist, does not affect 605 the reflexes and associated EPSP recorded in vitro, even though this same drug readily antagonises the 606 action of exogenously applied α 2 receptor agonists on the reflexes. However, the α 2 receptor does appear to 607 be spontaneously active in vivo, providing a tonic inhibition of reflex transmission, because the reflexes 608 and spasms are facilitated by the α 2 antagonists RX821002. We suggest that this spontaneous α 2 receptor 609 activity is due to a peripheral source of NA, which would also activate α 1 receptors as discussed above. 610 611 Interestingly, our conclusions might also explain the recent surprising finding that the α 2 receptor 612 antagonist yohimbine markedly facilitates locomotion in transected mice (Lapointe et al. 2008) . That is, a 613 peripheral source of NA may tonically inhibits locomotor activity, perhaps by inhibiting reflex 614 transmission, as we have seen, and antagonists may remove this inhibition. In contrast, α 1 receptor 615 activation facilitates rhythmic locomotor activity (Gabbay and Lev-Tov 2004) , in addition to its facilitation 616 of motoneuron excitability. 617 618
Implications for recovery of motor function. 619
Considering the pronounced opposing effects of α 1 and α 2 receptors that we have uncovered after chronic 620 SCI, the combined functional outcomes of activity in these two receptors remains to be considered. Since 621 the α 1 receptor is both constitutively active and activated by an endogenous source of NA (or other ligand; 622 peripherally-derived), whereas α 2 receptors are only activated by endogenous NA, the former α 1 receptor 623 activity is likely to dominate when there is not much endogenous NA, ultimately increasing spasms. 624 However, the levels of endogenous NA are likely to vary, especially as it appears to be peripherally 625 derived, perhaps of autonomic origin, and thus it is interesting to consider what the net effect of this 626 variable peripheral NA should be. Previously, we have shown that very low concentrations of exogenously 627 applied NA can facilitate spasms (LLRs) as well as increase motoneuron firing, whereas higher 628 concentrations tend to decrease spasms (Li et al. 2004b ), suggesting that there should be a similar biphasic 629 action of endogenous NA. Interestingly, increasing release of endogenous NA with amphetamine increases 630 spasms even at high doses (Rank et al. 2007 ), but this may be because amphetamine also binds directly to 631 α 2 adrenergic receptors (with similar affinity to NA itself; Boyajian and Leslie 1987) , and thus may 632 competitively block the action of released NA on the α 2 receptors, making the α 1 receptor action of NA 633 dominate. With more natural release of peripheral NA, the net effect of high levels of NA is likely to be 634 inhibitory, or antispastic in action, as we have discussed. This fits with our understanding of the dual 635 action of NA receptors, because regardless of how large the α 1 receptor-mediated PICs, if there are no 636
EPSPs to trigger them, because of α 2 receptor activity, there will not be spasms. Thus, interventions that 637 increase endogenous NA after SCI may well have antispastic benefits, while also increasing overall motor 638 output (PICs) and motor functions (locomotion; via α 1 ) (Gabbay and Lev-Tov 2004) 
